Literature DB >> 33096040

Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses.

Jenna J Guthmiller1, Linda Yu-Ling Lan2, Monica L Fernández-Quintero3, Julianna Han4, Henry A Utset1, Dalia J Bitar1, Natalie J Hamel1, Olivia Stovicek1, Lei Li1, Micah Tepora1, Carole Henry1, Karlynn E Neu5, Haley L Dugan2, Marta T Borowska6, Yao-Qing Chen1, Sean T H Liu7, Christopher T Stamper2, Nai-Ying Zheng1, Min Huang1, Anna-Karin E Palm1, Adolfo García-Sastre8, Raffael Nachbagauer7, Peter Palese7, Lynda Coughlan9, Florian Krammer7, Andrew B Ward4, Klaus R Liedl3, Patrick C Wilson10.   

Abstract

Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens and is a common feature of antibodies induced upon pathogen exposure. However, little is known about the role of polyreactivity during anti-influenza virus antibody responses. By analyzing more than 500 monoclonal antibodies (mAbs) derived from B cells induced by numerous influenza virus vaccines and infections, we found mAbs targeting conserved neutralizing influenza virus hemagglutinin epitopes were polyreactive. Polyreactive mAbs were preferentially induced by novel viral exposures due to their broad viral binding breadth. Polyreactivity augmented mAb viral binding strength by increasing antibody flexibility, allowing for adaption to imperfectly conserved epitopes. Lastly, we found affinity-matured polyreactive B cells were typically derived from germline polyreactive B cells that were preferentially selected to participate in B cell responses over time. Together, our data reveal that polyreactivity is a beneficial feature of antibodies targeting conserved epitopes.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antibody flexibility; broadly neutralizing antibodies; influenza viruses; monoclonal antibodies; polyreactivity

Mesh:

Substances:

Year:  2020        PMID: 33096040      PMCID: PMC7772752          DOI: 10.1016/j.immuni.2020.10.005

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  83 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 2.  Conformations of immunoglobulin hypervariable regions.

Authors:  C Chothia; A M Lesk; A Tramontano; M Levitt; S J Smith-Gill; G Air; S Sheriff; E A Padlan; D Davies; W R Tulip
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

3.  An Efficient Method to Generate Monoclonal Antibodies from Human B Cells.

Authors:  Jenna J Guthmiller; Haley L Dugan; Karlynn E Neu; Linda Yu-Ling Lan; Patrick C Wilson
Journal:  Methods Mol Biol       Date:  2019

4.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse.

Authors:  M J Shlomchik; A H Aucoin; D S Pisetsky; M G Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

Authors:  Barton F Haynes; Judith Fleming; E William St Clair; Herman Katinger; Gabriela Stiegler; Renate Kunert; James Robinson; Richard M Scearce; Kelly Plonk; Herman F Staats; Thomas L Ortel; Hua-Xin Liao; S Munir Alam
Journal:  Science       Date:  2005-04-28       Impact factor: 47.728

6.  Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin.

Authors:  James R R Whittle; Ruijun Zhang; Surender Khurana; Lisa R King; Jody Manischewitz; Hana Golding; Philip R Dormitzer; Barton F Haynes; Emmanuel B Walter; M Anthony Moody; Thomas B Kepler; Hua-Xin Liao; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

7.  Rapid development of broadly influenza neutralizing antibodies through redundant mutations.

Authors:  Leontios Pappas; Mathilde Foglierini; Luca Piccoli; Nicole L Kallewaard; Filippo Turrini; Chiara Silacci; Blanca Fernandez-Rodriguez; Gloria Agatic; Isabella Giacchetto-Sasselli; Gabriele Pellicciotta; Federica Sallusto; Qing Zhu; Elisa Vicenzi; Davide Corti; Antonio Lanzavecchia
Journal:  Nature       Date:  2014-10-05       Impact factor: 49.962

8.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Authors:  Jens Wrammert; Kenneth Smith; Joe Miller; William A Langley; Kenneth Kokko; Christian Larsen; Nai-Ying Zheng; Israel Mays; Lori Garman; Christina Helms; Judith James; Gillian M Air; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nature       Date:  2008-04-30       Impact factor: 49.962

9.  Origins of the 2009 H1N1 influenza pandemic in swine in Mexico.

Authors:  Ignacio Mena; Martha I Nelson; Francisco Quezada-Monroy; Jayeeta Dutta; Refugio Cortes-Fernández; J Horacio Lara-Puente; Felipa Castro-Peralta; Luis F Cunha; Nídia S Trovão; Bernardo Lozano-Dubernard; Andrew Rambaut; Harm van Bakel; Adolfo García-Sastre
Journal:  Elife       Date:  2016-06-28       Impact factor: 8.140

10.  Characterizing the Diversity of the CDR-H3 Loop Conformational Ensembles in Relationship to Antibody Binding Properties.

Authors:  Monica L Fernández-Quintero; Johannes R Loeffler; Johannes Kraml; Ursula Kahler; Anna S Kamenik; Klaus R Liedl
Journal:  Front Immunol       Date:  2019-01-07       Impact factor: 7.561

View more
  20 in total

1.  Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus.

Authors:  Maya Sangesland; Alba Torrents de la Peña; Seyhan Boyoglu-Barnum; Larance Ronsard; Faez Amokrane Nait Mohamed; Thalia Bracamonte Moreno; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; Musie Ghebremichael; Masaru Kanekiyo; Andrew Ward; Daniel Lingwood
Journal:  Immunity       Date:  2022-08-10       Impact factor: 43.474

2.  Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity.

Authors:  Jocelyn G Labombarde; Meenu R Pillai; Marie Wehenkel; Chun-Yang Lin; Rachael Keating; Scott A Brown; Jeremy Chase Crawford; David C Brice; Ashley H Castellaw; Alexandra H Mandarano; Clifford S Guy; Juan R Mejia; Carlessia D Lewis; Ti-Cheng Chang; Christine M Oshansky; Sook-San Wong; Richard J Webby; Mei Yan; Quan-Zhen Li; Tony N Marion; Paul G Thomas; Maureen A McGargill
Journal:  Cell Rep       Date:  2022-03-08       Impact factor: 9.995

3.  Parallelism of intestinal secretory IgA shapes functional microbial fitness.

Authors:  Hedda Wardemann; Andrew J Macpherson; Tim Rollenske; Sophie Burkhalter; Lukas Muerner; Stephan von Gunten; Jolanta Lukasiewicz
Journal:  Nature       Date:  2021-10-13       Impact factor: 69.504

4.  Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection.

Authors:  Dídac Macià; Joseph J Campo; Gemma Moncunill; Chenjerai Jairoce; Augusto J Nhabomba; Maximilian Mpina; Hermann Sorgho; David Dosoo; Ousmane Traore; Kwadwo Asamoah Kusi; Nana Aba Williams; Amit Oberai; Arlo Randall; Hèctor Sanz; Clarissa Valim; Kwaku Poku Asante; Seth Owusu-Agyei; Halidou Tinto; Selidji Todagbe Agnandji; Simon Kariuki; Ben Gyan; Claudia Daubenberger; Benjamin Mordmüller; Paula Petrone; Carlota Dobaño
Journal:  JCI Insight       Date:  2022-05-23

5.  B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.

Authors:  Johannes F Scheid; Christopher O Barnes; Basak Eraslan; Andrew Hudak; Jennifer R Keeffe; Lisa A Cosimi; Eric M Brown; Frauke Muecksch; Yiska Weisblum; Shuting Zhang; Toni Delorey; Ann E Woolley; Fadi Ghantous; Sung-Moo Park; Devan Phillips; Betsabeh Tusi; Kathryn E Huey-Tubman; Alexander A Cohen; Priyanthi N P Gnanapragasam; Kara Rzasa; Theodora Hatziioanno; Michael A Durney; Xiebin Gu; Takuya Tada; Nathaniel R Landau; Anthony P West; Orit Rozenblatt-Rosen; Michael S Seaman; Lindsey R Baden; Daniel B Graham; Jacques Deguine; Paul D Bieniasz; Aviv Regev; Deborah Hung; Pamela J Bjorkman; Ramnik J Xavier
Journal:  Cell       Date:  2021-04-24       Impact factor: 66.850

Review 6.  Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.

Authors:  Lucas J Kerstetter; Stephen Buckley; Carly M Bliss; Lynda Coughlan
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

7.  Ensembles in solution as a new paradigm for antibody structure prediction and design.

Authors:  Monica L Fernández-Quintero; Guy Georges; Janos M Varga; Klaus R Liedl
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 8.  B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.

Authors:  Jenna J Guthmiller; Henry A Utset; Patrick C Wilson
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

9.  An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines.

Authors:  Jenna J Guthmiller; Henry A Utset; Carole Henry; Lei Li; Nai-Ying Zheng; Weina Sun; Marcos Costa Vieira; Seth Zost; Min Huang; Scott E Hensley; Sarah Cobey; Peter Palese; Patrick C Wilson
Journal:  mBio       Date:  2021-06-15       Impact factor: 7.867

Review 10.  Understanding Antibody Responses in Early Life: Baby Steps towards Developing an Effective Influenza Vaccine.

Authors:  Elene A Clemens; Martha A Alexander-Miller
Journal:  Viruses       Date:  2021-07-17       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.